MeiraGTx Holdings (MGTX) Net Cash Flow Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 351.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 351.01% |
| Sep 30, 2025 | -154.85% |
| Jun 30, 2025 | -104.79% |
| Mar 31, 2025 | -245.09% |
| Dec 31, 2024 | -131.47% |
| Sep 30, 2024 | 183.23% |
| Jun 30, 2024 | -180.06% |
| Mar 31, 2024 | 77.41% |
| Dec 31, 2023 | 86,848.65% |
| Sep 30, 2023 | -167.24% |
| Jun 30, 2023 | 157.31% |
| Mar 31, 2023 | -102.35% |
| Dec 31, 2022 | 101.41% |
| Sep 30, 2022 | 245.39% |
| Jun 30, 2022 | -57.09% |
| Mar 31, 2022 | -141.97% |
| Dec 31, 2021 | -117.70% |
| Sep 30, 2021 | -83.26% |
| Jun 30, 2021 | -68.42% |
| Mar 31, 2021 | 40.66% |
| Dec 31, 2020 | 211.25% |
| Sep 30, 2020 | -131.83% |
| Jun 30, 2020 | 30.82% |
| Mar 31, 2020 | -110.25% |
| Dec 31, 2019 | -30.85% |
| Sep 30, 2019 | 469.52% |
| Jun 30, 2019 | -132.66% |
| Mar 31, 2019 | 566.59% |
| Dec 31, 2018 | -722.69% |
| Sep 30, 2018 | -9,752.18% |